ReviewAdvances in ophthalmology practice and research
Cataract: Surgery first - is there still room for basic research?
Review in Advances in ophthalmology practice and research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cataract is the leading cause of blindness worldwide, with surgery being the only effective treatment. Driven by advanced techniques and innovative functional intraocular lenses (IOLs), cataract surgery has achieved a remarkable paradigm shift from vision restoration to refractive surgery. This dominance of surgery raises a core question: Is there still room for basic research? Main text: Basic research remains vital to addressing unmet challenges in cataract care. The lens serves as an ideal biological model for studying fundamental processes. In addition, efforts to enable cataract prevention and early intervention focus on investigating its etiology, including genetic susceptibility and environmental exposure. Pharmacological research investigates potentials for delaying or even reversing early-stage lens opacification. For intraocular lens (IOL) performance enhancement, advances in material science boost biocompatibility of IOLs, while insights from lens biomechanics further refine IOL design for better long-term stability. To address posterior capsule opacification (PCO), a key postoperative issue, efforts center on developing drug-coated IOLs and sustained-release delivery systems. Lastly, lens regeneration research explores activating residual lens epithelial cells (LECs) for in situ regeneration and tackles challenges in culturing functional lens tissue in vitro. Conclusions: The success of cataract surgery does not diminish the value of basic research. Instead, collaboration between clinicians and basic researchers, along with increased investment in basic research, will drive breakthroughs in cataract prevention and treatment, enabling natural, long-term vision beyond just clear sight.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.